Low-dose interleukin-2 for the reduction of vascular inflammation in acute coronary syndromes (IVORY) / IVORY - Clinical Outcomes And Follow-up (IVORY FINALE) Study

30 August 2024 (08:15 - 08:26)
Organised by: Logo
Congress Presentation Part of: Smaller trials, trial updates, and other studies on inflammation and immunity in cardiovascular disease Pharmacotherapy ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology